Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The NCI60 human tumour cell line anticancer drug screen.

Shoemaker RH.

Nat Rev Cancer. 2006 Oct;6(10):813-23. Review.

PMID:
16990858
2.

Anticancer drug development at the US National Cancer Institute.

Takimoto CH.

Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S29-33. Epub 2003 Jun 18.

PMID:
12819935
3.

The NCI Developmental Therapeutics Program.

Collins JM.

Clin Adv Hematol Oncol. 2006 Apr;4(4):271-3. Review. No abstract available.

PMID:
16728938
4.

Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines.

Holbeck SL, Collins JM, Doroshow JH.

Mol Cancer Ther. 2010 May;9(5):1451-60. doi: 10.1158/1535-7163.MCT-10-0106. Epub 2010 May 4.

5.

[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].

Bissery MC, Chabot GG.

Bull Cancer. 1991;78(7):587-602. Review. French.

PMID:
1912670
6.

Natural product drug discovery and development: the United States National Cancer Institute role.

Cragg GM.

P R Health Sci J. 2002 Jun;21(2):97-111. No abstract available.

PMID:
12166031
7.
8.
9.

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.

Kong D, Yamori T.

Bioorg Med Chem. 2012 Mar 15;20(6):1947-51. doi: 10.1016/j.bmc.2012.01.017. Epub 2012 Jan 21. Review.

10.

Origins and development of chemotherapy research at the National Cancer Institute.

Zubrod CG.

Cancer Treat Rep. 1984 Jan;68(1):9-19. No abstract available.

PMID:
6362871
11.

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJ Jr, Kohn KW.

Cancer Res. 1997 Oct 1;57(19):4285-300.

12.

Translational cancer research in the USA.

Brown H.

Mol Oncol. 2007 Jun;1(1):11-3. No abstract available.

13.

A history of cancer chemotherapy.

DeVita VT Jr, Chu E.

Cancer Res. 2008 Nov 1;68(21):8643-53. doi: 10.1158/0008-5472.CAN-07-6611.

14.
15.

Update on NCI in vitro drug screen utilities.

Holbeck SL.

Eur J Cancer. 2004 Apr;40(6):785-93.

PMID:
15120034
18.

The role of the National Cancer Institute in drug development.

Doroshow J.

Clin Adv Hematol Oncol. 2005 Apr;3(4):257-8. No abstract available.

PMID:
16166997
19.

Phenotypic screening in cancer drug discovery - past, present and future.

Moffat JG, Rudolph J, Bailey D.

Nat Rev Drug Discov. 2014 Aug;13(8):588-602. doi: 10.1038/nrd4366. Epub 2014 Jul 18. Review.

PMID:
25033736
20.

[Antitumor drug screening at the National Cancer Institute, U.S.A].

Tsuruo T.

Gan To Kagaku Ryoho. 1987 Oct;14(10):2809-15. Review. Japanese.

PMID:
3310904

Supplemental Content

Support Center